
    
      Title of study extension: An open-label, multicenter extension to evaluate the efficacy and
      tolerability of a 4 week therapy with hydrochlorothiazide 12.5 mg plus amlodipine 10
      mg/valsartan 160 mg in hypertensive patients not adequately responding to a 4 week therapy
      each with the combinations of olmesartan 20 mg plus amlodipine 10 mg followed by amlodipine
      10 mg/valsartan 160 mg
    
  